Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Gelbenegger

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Journal of Internal Medicine|March 5, 2025
Systolic blood pressure targets below 120 mm Hg are associated with reduced mortality: A meta-analysisFelix Bergmann, Marlene Prager, Lena Pracher, et al.
Vascular Pharmacology|March 23, 2021
Optimal duration and combination of antiplatelet therapies following percutaneous coronary intervention: a meta-analysisGeorg Gelbenegger, Ummahan Erari-Canyurt, Jürgen Grafeneder, et al.
Frontiers in Cardiovascular Medicine|August 2, 2021
Cardiovascular Outcome in Patients Treated With SGLT2 Inhibitors for Heart Failure: A Meta-AnalysisGloria M Gager, Georg Gelbenegger, Bernd Jilma, et al.
Clinical Pharmacology and Therapeutics|March 5, 2021
Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Percutaneous Coronary Intervention: A Meta-AnalysisGeorg Gelbenegger, Christian Schoergenhofer, Bernd Jilma, et al.
Infection|June 8, 2025
Antimicrobial treatment for 7 versus 14 days in patients with bacteremia: a meta-analysis of randomized controlled trialsMarlene Prager, Felix Bergmann, Lena Pracher, et al.
Scientific Reports|February 5, 2021
The aptamer BT200 blocks von Willebrand factor and platelet function in blood of stroke patientsKatarina D Kovacevic, Stefan Greisenegger, Agnes Langer, et al.
The American Journal of Medicine|September 16, 2024
Association of Electrocardiogram Findings With Clinical Outcomes in Patients With Chronic Coronary Syndrome: An Analysis of the ISCHEMIA TrialsAnselm Jorda, Theresa Pecho, Lisa Christina Horvath, et al.
Vascular Pharmacology|April 28, 2023
Endovascular thrombectomy with or without intravenous thrombolysis in large-vessel ischemic stroke: A non-inferiority meta-analysis of 6 randomised controlled trialsLisa Christina Horvath, Felix Bergmann, Arthur Hosmann, et al.
Research and Practice in Thrombosis and Haemostasis|September 13, 2024
Pharmacokinetics and pharmacodynamics of low doses of recombinant tissue plasminogen activator to establish a model for biosimilarity comparisonsUlla Derhaschnig, Nina Buchtele, Margarete M Steiner, et al.
Journal of Clinical Medicine|February 27, 2020
High Platelet Reactivity after Transition from Cangrelor to Ticagrelor in Hypothermic Cardiac Arrest Survivors with ST-Segment Elevation Myocardial InfarctionNina Buchtele, Harald Herkner, Christian Schörgenhofer, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Journal of Internal Medicine|March 5, 2025
Systolic blood pressure targets below 120 mm Hg are associated with reduced mortality: A meta-analysisFelix Bergmann, Marlene Prager, Lena Pracher, et al.
Vascular Pharmacology|March 23, 2021
Optimal duration and combination of antiplatelet therapies following percutaneous coronary intervention: a meta-analysisGeorg Gelbenegger, Ummahan Erari-Canyurt, Jürgen Grafeneder, et al.
Frontiers in Cardiovascular Medicine|August 2, 2021
Cardiovascular Outcome in Patients Treated With SGLT2 Inhibitors for Heart Failure: A Meta-AnalysisGloria M Gager, Georg Gelbenegger, Bernd Jilma, et al.
Clinical Pharmacology and Therapeutics|March 5, 2021
Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Percutaneous Coronary Intervention: A Meta-AnalysisGeorg Gelbenegger, Christian Schoergenhofer, Bernd Jilma, et al.
Infection|June 8, 2025
Antimicrobial treatment for 7 versus 14 days in patients with bacteremia: a meta-analysis of randomized controlled trialsMarlene Prager, Felix Bergmann, Lena Pracher, et al.
Scientific Reports|February 5, 2021
The aptamer BT200 blocks von Willebrand factor and platelet function in blood of stroke patientsKatarina D Kovacevic, Stefan Greisenegger, Agnes Langer, et al.
The American Journal of Medicine|September 16, 2024
Association of Electrocardiogram Findings With Clinical Outcomes in Patients With Chronic Coronary Syndrome: An Analysis of the ISCHEMIA TrialsAnselm Jorda, Theresa Pecho, Lisa Christina Horvath, et al.
Vascular Pharmacology|April 28, 2023
Endovascular thrombectomy with or without intravenous thrombolysis in large-vessel ischemic stroke: A non-inferiority meta-analysis of 6 randomised controlled trialsLisa Christina Horvath, Felix Bergmann, Arthur Hosmann, et al.
Research and Practice in Thrombosis and Haemostasis|September 13, 2024
Pharmacokinetics and pharmacodynamics of low doses of recombinant tissue plasminogen activator to establish a model for biosimilarity comparisonsUlla Derhaschnig, Nina Buchtele, Margarete M Steiner, et al.
Journal of Clinical Medicine|February 27, 2020
High Platelet Reactivity after Transition from Cangrelor to Ticagrelor in Hypothermic Cardiac Arrest Survivors with ST-Segment Elevation Myocardial InfarctionNina Buchtele, Harald Herkner, Christian Schörgenhofer, et al.
Pageof 6